 Primary trial objective in this single arm trial is to assess the safety and tolerability of Selectikine EMD 521873 given in combination with and local tumor irradiation and to determine whether the maximum tolerated dose MTD is reached with EMD 521873 doses of up to 0.45 mgkg. 